VarmX
varmx.com
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$67M
3 rounds on record
Latest round
$32.4M
Series B · May 2023 · 3 yr ago
Team
51-200
employees, estimated range
Grants
$2.7M
1 grant · CORDIS
Backers
5
BioGeneration Ventures, Inkef
The money's age
Long since its last round
40 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 15
Recognition VarmX recognised with two prestigious industry award nominations · varmx.com
Jan 8
Partnership VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization · varmx.com
Sep 16, 2025
Partnership VarmX partners with CSL in a strategic collaboration and option agreement to develop novel investigational coagulation treatment · varmx.com
Mar 8, 2023
New executive VarmX Appoints Dr. Jeffrey Lawson, MD, PhD as Chief Scientific Officer · DutchNews.nl
Sep 1, 2022
Won a grant $2.7M · CORDIS
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | May 2023 | $32.4M | — | businesswire.com |
| Grant | Sep 2022 | $2.7M | — | CORDIS |
| Series B | Jul 2020 | $34.6M | — | DutchNews.nl |
Backed byfrom the funds' portfolios and accelerator catalogs
Inkef 
InnovationQuarter 
Sound Bioventures 
Ysios Capital Similar startupsby what they do, their industry and backers
Our plant-based technology stops traumatic and surgical bleeds in seconds without the need for manual pressure. Stop bleeding in seconds.
Airsonett offers effective treatment of allergic asthma and atopic dermatitis – no pharmacological side effects. 99,5% allergen-free air…
Developing a meniscus implant for the treatment of persistent knee pain and prevention of arthritis in patients with prior meniscus injury.
Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS)…
Better medicine, fast.. Partner with us.
Lightening the burden of oral mucositis. Clinical findings showed fewer patients developing severe OM, fewer days with severe OM and less…
News
VarmX and CSL Form Strategic Collaboration Effort to Develop VMX-C001 PharmExec
VarmX partners with CSL to advance VMX-C001, a groundbreaking treatment for patients on FXa DOACs, enhancing surgical outcomes and patient care.
Read more
Report
VarmX recognised with two prestigious industry award nominations
Nominated for the 2026 Prix Galien USA "Best Startup" Award, and shortlisted with partner CSL for "Deal of the Year" at the 2026 European Lifestars AwardsLeiden, The Netherlands, 15 September 2026 - VarmX, a biotech company developing innovative approache
Read more
Report
VarmX enrols first participant in global Phase 3 EquilibriX-S trial evaluating VMX C001 in urgent surgery
VarmX enrols first participant in global Phase 3 EquilibriX-S trial evaluating VMX-C001 in urgent surgeryFirst participant enrolled: EquilibriX-S ...
Read more
Report
VarmX enrols first participant in global Phase 3 EquilibriX-S trial evaluating VMX C001 in urgent surgery
VarmX enrols first participant in global Phase 3 EquilibriX-S trial
Read more
Report
VarmX enrols first participant in global Phase 3 EquilibriX-S trial evaluating VMX-C001 in urgent surgery
First participant enrolled: EquilibriX-S (NCT07288489), a landmark registrational Phase 3 study of VMX-C001 vs usual pharmacologic care in patients taking FXa inhibitors who require an urgent surgery/procedure, has begun enrolmentGlobal scope: Participant
Read more
Report
Pro access
Upgrade to see all 20 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.